Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2316 (LINC02316)

Target
LINC02316
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2316 (LINC02316) is a member of the long intergenic non-coding RNA class, consisting of RNA transcripts that do not overlap protein-coding genes and are generally longer than 200 nucleotides[3][5]. LINC02316, like other lincRNAs, is presumed to exert cellular functions primarily through the regulation of gene expression, acting in the nucleus or cytoplasm via mechanisms such as controlling chromatin state or modulating the pool of regulatory microRNAs[5][1]. Specific biological or disease roles for LINC02316 itself have not been described in the scientific literature to date, and it is not recognized as a therapeutic target or as having reported drug interactions. The broader lincRNA family has demonstrated roles in regulation of cell proliferation and apoptosis, particularly in cancer contexts, but such attributions for LINC02316 remain uncharacterized and should not be assumed without direct evidence[5][3].

Other names
LINC02316
02

Biological functions

Gene regulationRegulation of chromatin structure (based on lincRNA family function)Modulation of microRNA availability (inferred from the family)[5]
03

Disease associations

Cancer (by molecular class association, not specific to LINC02316)[5]Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2316 (LINC02316).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2316 (LINC02316).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call